More Company News

Redx Pharma

H122 interim results
23 Jun 2022Read More

Redx Pharma

Pan-RAF inhibitor to enter clinic
15 Jun 2022Read More

Redx Pharma

Poster on RXC004 at ASCO 2022
30 May 2022Read More

Redx Pharma

Result of accelerated book build
19 May 2022Read More

Redx Pharma

Launch of placing via accelerated book build
18 May 2022Read More

Redx Pharma

RXC004 data to be presented at ASCO
27 Apr 2022Read More

Redx Pharma

RXC004 preclinical data presented at AACR
08 Apr 2022Read More

Redx Pharma

Collaboration with Garvan Institute of Medical Research
05 Apr 2022Read More

Redx Pharma

RXC008 nominated as GI ROCK clinical development candidate
30 Mar 2022Read More

Redx Pharma

Encouraging RXC007 Phase I safety data
10 Mar 2022Read More

1 2 3 4
Return to Redx Pharma
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).